A standing order in effect statewide since 2015 allows any adult in Indiana to purchase naloxone without a prescription from registered pharmacies. Both health care professionals and recovery advocates say the FDA’s decision could make Narcan more widely accessible.

The IU School of Public Health in Bloomington has received a $1.7 million grant from the Department of Health and Human Services to investigate the role of structural racism in stigmatization and deaths from opioid use in the Indianapolis African American community.

Nearly every state has laws that limit access to opioid treatment programs, according to a new report from the Pew Charitable Trusts.

All of Indiana's more than 600 political subdivisions have agreed to take part in a $507 million statewide settlement with opioid makers and distributors, Indiana's attorney general's office said.

Indiana is set to receive more than $500 million over the next two decades from a settlement with opioid manufacturers.

The Wabash office is partnering with Overdose Lifeline and a local nurse to ensure a box is stocked with single dose kits for any community members to come in and grab.

The Indiana State Nursing Board violated federal law by discriminating against nurses with substance use disorders, according to a Department of Justice finding.

The new data from the U.S. Centers for Disease Control and Prevention suggests the opioid epidemic is far from over, and public health officials say fentanyl — a synthetic opioid that is much more deadly than other opioids — is largely to blame.

The funds will provide participants with training in jobs that address the impact of the opioid crisis, including recovery coaches, peer navigators and community health workers.

Indiana will receive $507 million as part of a multi-state agreement to settle a lawsuit against opioid distributors designed to bring relief to people struggling with addiction to the drug, officials said Wednesday.